THE PHARMACOKINETICS OF NEDOCROMIL SODIUM, A NEW DRUG FOR THE TREATMENT OF REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASE, IN HUMAN VOLUNTEERS AND PATIENTS WITH REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASE

被引：31

作者：

NEALE, MG

BROWN, K

FOULDS, RA

LAL, S

MORRIS, DA

THOMAS, D

机构：

[1] FISONS PLC,DEPT DRUG METAB,LOUGHBOROUGH LE11 ORH,LEICS,ENGLAND

[2] BUR GEN HOSP,CHEST UNIT,BURY,LANCS,ENGLAND

来源：

关键词：

D O I：

10.1111/j.1365-2125.1987.tb03203.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：493 / 501

页数：9

共 17 条

[11] NEWMAN SP, 1981, THORAX, V36, P52, DOI 10.1136/thx.36.1.52
[12] ORR TSC, 1986, ASTHMA CLIN PHARM TH, P265
[13] ATTENUATION OF EXERCISE-INDUCED ASTHMA BY PRETREATMENT WITH NEDOCROMIL SODIUM AND MINOCROMIL
ROBERTS, JA
THOMSON, NC
[J]. CLINICAL ALLERGY, 1985, 15 (04): : 377 - 381
[14] RUFFIN RE, 1986, RECENT ADV AIRWAY DI, P15
[15] NEDOCROMIL, A MUCOSAL AND CONNECTIVE-TISSUE MAST-CELL STABILIZER, INHIBITS EXERCISE-INDUCED ASTHMA
SHAW, RJ
KAY, AB
[J]. BRITISH JOURNAL OF DISEASES OF THE CHEST, 1985, 79 (04): : 385 - 389
[16] WAGNER JG, 1975, FUNDAMENTALS CLIN PH, P100
[17] EFFECT OF NEDOCROMIL SODIUM ON THE IMMEDIATE RESPONSE TO ANTIGEN CHALLENGE IN ASTHMATIC-PATIENTS
YOUNGCHAIYUD, P
LEE, TB
[J]. CLINICAL ALLERGY, 1986, 16 (02): : 129 - 134